ADVANCES IN OCULAR DRUG DELIVERY SYSTEMS FOR THE TREATMENT AND MANAGEMENT OF CATARACTS: A REVIEW
DOI:
https://doi.org/10.53555/eijbps.v11i1.63Keywords:
Cataract, ocular drug delivery, nanoparticlesAbstract
Cataracts remain the leading cause of visual impairment worldwide, primarily managed through surgical intervention. However, growing interest in pharmacological strategies for prevention and adjunct therapy has propelled innovation in ocular drug delivery systems. This review outlines the pathophysiology of cataracts, evaluates the limitations of conventional treatment methods, and presents recent advancements in drug delivery systems, including nanoparticles, liposomes, in situ gels, contact lenses, and microneedles. These systems offer targeted, sustained, and non-invasive delivery of therapeutic agents, potentially transforming cataract management.
References
Giri BR, Jakka D, Sandoval MA, Kulkarni VR, Bao Q. Advancements in Ocular Therapy: A Review of Emerging Drug Delivery Approaches and Pharmaceutical Technologies. *Pharmaceutics*. 2024;16(10):1325.
Ashtekar KS, Monde AA, Nilangekar P, Bagul U, Nazirkar M, Kokare C. A review on nanotechnology-based ophthalmic drug delivery systems. *J Drug Deliv Ther*. 2023;13(12):262-9.
Tian B, Bilsbury E, Doherty S, Teebagy S, Wood E, Su W, et al. Ocular Drug Delivery: Advancements and Innovations. *Pharmaceutics*. 2022;14(9):1931.
Chen Y, Ye Z, Chen H, Li Z. Breaking Barriers: Nanomedicine-Based Drug Delivery for Cataract Treatment. *Int J Nanomedicine*. 2024;19:4021–40.
Zhou Y, et al. Recent Advances in Nanomedicine for Ocular Fundus Neovascularization Disease Management. *Adv Healthc Mater*. 2024;13(3):e2304626.
Silva-Cunha A. Advances in Ocular Drug Delivery Systems. *Pharmaceutics*. 2021;13(9):1383.
Choursiya KA, Kandalkar SG, Shaikh SR, Gangurde PK, Jadhav KR, Nikam SM, Bachhav RS. Advancements In Ocular Drug Delivery System: A Comprehensive Review. *Int J Pharm Sci*. 2024;2(5):758–75.
Bhatt P, et al. Innovations in ocular drug delivery. *South Asian J Health Prof*. 2023;10(2):45–52.
Bisen PS, et al. A review on polymers in ocular drug delivery systems. *MedComm Biomater Appl*. 2024;3(1):e77.
Truscott RJ. Age-related nuclear cataract-oxidation is the key. Exp Eye Res. 2005 Mar;80(5):709-25. doi:10.1016/j.exer.2004.12.007.
Michael R, Bron AJ. The ageing lens and cataract: a model of normal and pathological ageing. Philos Trans R Soc Lond B Biol Sci. 2011 Jan 27;366(1568):1278-92. doi:10.1098/rstb.2010.0300.
Nagaraj RH, Sell DR, Prabhakaram M, Ortwerth BJ, Monnier VM. High correlation between pentosidine protein cross-links and fluorescence in human lens and skin in individual donors. FEBS Lett. 1991 Nov 18;290(1-2):115-9. doi:10.1016/0014-5793(91)81242-Z.
Azuma M, Shearer TR. The role of calcium in cataract formation. Curr Eye Res. 1993 Jul;12(7):653-7. doi:10.3109/02713689308999469.
Shiels A, Hejtmancik JF. Genetic origins of cataract. Arch Ophthalmol. 2007 Feb;125(2):165-73. doi:10.1001/archopht.125.2.165.
Michael R, van Marle J, Vrensen GF. Light microscopic and ultrastructural changes in the lens epithelium of human donor eyes after UV-B irradiation. Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3148-57.
Zhang X, Li Y, Wang Y, et al. Cyclic cell-penetrating peptide-engineered ceria nanoparticles for non-invasive alleviation of ultraviolet radiation-induced cataract. J Nanobiotechnol. 2025;23(1):337.
Fayazbakhsh F, Hataminia F, Eslam HM, et al. Gold nanoparticles encapsulated resveratrol as an anti-aging agent to delay cataract development. Sci Rep. 2023;13(1):21344.
Cai R, Zhang L, Chi H. Recent development of polymer nanomicelles in the treatment of eye diseases. Front Bioeng Biotechnol. 2023;11:1246974
Wang Y, Hu Y, An J, Zhang H, Liu X, Li X, Zhang Z, Zhang X. Liposome-based permeable eyedrops for effective posterior segment drug delivery. Adv Funct Mater. 2024;34(39):2403142
Gu H, Chen P, Liu X, Lian Y, Xi J, Li J, Song J, Li X. Trimethylated chitosan-coated flexible liposomes with resveratrol for topical drug delivery to reduce blue-light-induced retinal damage. Int J Biol Macromol. 2023;252:126480.
Zhou Y, Zhang Y, Wang J, Li X, Li Y. Recent advances in nanomedicine for ocular fundus neovascularization disease management. Adv Healthc Mater. 2024;13(5):e2304626.
Tang H, Li X, Jin L, Dong J, Yang L, Li C, Zhang L, Cheng F. Applications and latest research progress of liposomes in the treatment of ocular diseases. Biointerphases. 2025;20(1):011005
Chaudhuri A, Gauttam VK, Arushi A, Negi S, Singh G, Bharti B, et al. Design and Evaluation of Novel in situ Gel Forming Ocular Drug Delivery System of Kaempferol for Sustain Pharmacological Response against Cataract. Pharmacognosy Research. 2025;17(1):173-184
Kotreka UK, Davis VL, Adeyeye MC. Development of topical ophthalmic In Situ gel-forming estradiol delivery system intended for the prevention of age-related cataracts. PLoS One. 2017;12(2):e0172306.
Gözcü S, et al. Formulation of hesperidin‐loaded in situ gel for ocular drug delivery: a comprehensive study. J Sci Food Agric. 2024;104(5):1234-1242.
Kumara BN, Velmurugan K, Ghate MV, Shambhu R, Nirmal J, Prasad KS. A promising 'single' and 'dual' drug-nanocomposite enriched contact lens for the management of glaucoma in response to the tear fluid enzyme. J Mater Chem B. 2024;12(9):2394-2412.
Guo X, Sun Y, Qiao J, Fan B, Zhang X. Levofloxacin-loaded silicone contact lenses materials for ocular drug delivery. J Biomater Appl. 2025;39(5):1034-1042.
Torun L, Yildiz UH, Kocabas C. Microfluidic contact lenses for ocular diagnostics and drug delivery. Nano Select. 2023;4(1):1-14
Fitaihi R, Abukhamees S, Orlu M, Craig DQM. Transscleral delivery of dexamethasone-loaded microparticles using a dissolving microneedle array. Pharmaceutics. 2023;15(6):1622.
Wu Y, Vora LK, Donnelly RF, Singh TRR. Rapidly dissolving bilayer microneedles enabling minimally invasive and efficient protein delivery to the posterior segment of the eye. Drug Deliv Transl Res. 2023;13(10):2142–2158.
Shi H, Huai S, Wei H, Xu Y, Lei L, et al. Dissolvable hybrid microneedle patch for efficient delivery of curcumin to reduce intraocular inflammation. Int J Pharm. 2023;643:123205.
Ashtekar KS, Monde AA, Nilangekar P, Bagul U, Nazirkar M, Kokare C. A review on nanotechnology-based ophthalmic drug delivery systems. J Drug Deliv Ther. 2023;13(12):262-9.
